RECRUITING

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Official Title

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Quick Facts

Study Start:2020-08-20
Study Completion:2026-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04988009

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
  2. * Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be
  3. * An in-person visit
  4. * A telemedicine appointment
  1. * Encounter occurred with the assistance of official language translation support
  2. * Patients with telephone encounters (without interactive video)
  3. * New patient or consult visits
  4. * Neither patient nor caregiver present during the visit are available or able to answer survey questions

Contacts and Locations

Study Contact

Barbara J O'Brien, MD
CONTACT
713-794-4380
bjobrien@mdanderson.org

Principal Investigator

Barbara J O'Brien, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Barbara J O'Brien, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-08-20
Study Completion Date2026-12-31

Study Record Updates

Study Start Date2020-08-20
Study Completion Date2026-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Central Nervous System Neoplasm
  • Leptomeningeal Neoplasm
  • Metastatic Malignant Neoplasm in the Brain
  • Primary Brain Neoplasm